Paul Hudson, Sanofi CEO (Romuald Meigneux/Sipa via AP Images)

Sanofi and Am­gen are bring­ing cash to cov­er the ta­ble stakes for the Hori­zon M&A game

With the mar­ket cap on Hori­zon Ther­a­peu­tics $HZNP pushed up to the $23 bil­lion mark to­day, one of the Big Phar­mas in the hunt for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.